A preliminary study to be presented at an upcoming American Academy of Neurology conference claims teens with epilepsy treated with pharmaceutical CBD fared better than those using “artisanal” cannabidiol.
A preliminary study to be presented at an upcoming American Academy of Neurology conference claims teens with epilepsy treated with pharmaceutical CBD fared better than those using “artisanal” cannabidiol.